Claritev

Claritev Debt/EBITDA

The Total Debt to EBITDA Ratio of Claritev (CTEV) as of Oct 28, 2026 is 9.37. In the previous year, Total Debt to EBITDA Ratio was -4.47 — a change of -309.67% (higher).

Debt/EBITDA

9.37

YoY

-309.67%

Last updated:

Total Debt to EBITDA Ratio of Claritev is 2025 9.37 . Total Debt to EBITDA Ratio of Claritev was 2024 -4.47 . It decreases by -309.67% higher compared to the previous year.

The Claritev Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2019
7.12 USD
Jan 1, 2020
17.38 USD
Jan 1, 2021
6.18 USD
Jan 1, 2022
32.03 USD
Jan 1, 2023
7.81 USD
Jan 1, 2024
-4.47 USD
Jan 1, 2025
9.37 USD
The Claritev Debt/EBITDA history
YEARDebt/EBITDAYoY
9.37-309.67%
-4.47-157.20%
7.81-75.61%
32.03+418.00%
6.18-64.42%
17.38+144.09%
7.12—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Claritev Stock analysis

What does Claritev do? Claritev Corp generates revenue through its Analytics-Based Services, which uses data-driven algorithms to detect over-charges in healthcare claims and negotiate fair reimbursement for out-of-network costs. The company also offers Network-Based Services, including contracting discounts with providers to form independent PPOs and providing outsourced network development and management. Payment and Revenue Integrity Services identifies improper charges before or after claims are paid, while its SaaS platform delivers data analytics for healthcare cost management. Clients include healthcare providers, insurers, and employers seeking cost efficiency in medical billing and reimbursement processes. Claritev Corp's products target segments such as healthcare cost management, network development, and revenue integrity. The company's SaaS platform integrates descriptive, predictive, and prescriptive analytics to process data from multiple sources. Its services are designed to reduce overpayments and underpayments in healthcare claims, appealing to organizations focused on optimizing financial outcomes in medical billing. The business model relies on selling these integrated services to healthcare organizations, with a focus on data-driven solutions for cost control. Analytics-Based Services and Payment and Revenue Integrity Services directly address claim accuracy and reimbursement fairness, while Network-Based Services create cost-saving provider networks. The SaaS platform serves as the technological backbone for all offerings, enabling scalable data processing and insights. Claritev is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Claritev stock

Total Debt to EBITDA Ratio of Claritev is 9.37 in 2025.

Total Debt to EBITDA Ratio of Claritev changed from -4.47 to 9.37, representing a -309.67% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Claritev since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Claritev with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Claritev

All Key Metrics — Claritev